
Although Docusign Inc (NASDAQ:DOCU) reported healthy first-quarter results, its full-year billings guidance was disappointing, reflecting “choppy execution” according to BofA Securities.
The DocuSign Analyst: Brad Sills downgraded the rating for DocuSign from Buy to Neutral, while reducing the price target from $120 to $72.